Clinical Trial Management

Result-driven clinical research professional with 7 years of extensive experience providing research support, coordination, and leadership for studies that involve NIH sponsored, investigator-initiated, and industry-sponsored Phase II and III clinical trials. Ability to handle multiple projects simultaneously with a high degree of accuracy.
I have a list of ongoing and completed clinical trials which are mentioned below:
1. Personalized Integrated Chronotherapy for Perinatal Depression: PI- Dr. Samantha Meltzer-Brody November, 2020-present
2. Depression, Aging Stress and Heart Health Study (DASHH): PI- Dr. Margo Nathan, November 2022-present
3. Skylark Study (SAGE-217-PPD-301), Phase 3: PI- Dr.Meltzer-Brody February, 2021-May 2022
4. Robin Study (SAGE-217-PPD-201), Phase 2: PI- Dr. Meltzer-Brody, March 2018-March 2019
5. Chickadee Study (SAGE-547-PPD-304), Phase 3: PI- Dr. Meltzer-Brody, January 2020-May 2021
6. Hummingbird Study (SAGE-547-202B and 202C), Phase 3: PI- Dr. Meltzer-Brody, June 2017-September 2017
These trials are conducted to evaluate the safety and efficacy of various treatments for postpartum depression in women, including personalized integrated chronotherapy, Zuranolone, and SAGE 547. The trials are being conducted with the aim of improving the health and well-being of women suffering from postpartum depression.
Clinical Trial Management
Clinical Research Associate Positions
Prevention Research
Cancer Research
Cardiology
Neurology
Diabetes
Infectious Diseases
Drug Trials
Device Trials
EDC
IRT
Medidata
ERT
Microsoft Applications
REDCap
Site Vault
OnCore
Qualtrics